Insider buying last 90 days
$1.02Min 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 12 | Nick L Stanage Director | Purchase | $1.02M |
From Form 4 filings, dated to when each was filed.
NYSE: AME
AMETEK (AME) Stock Analysis & Forecast
$237.64+3.32 (+1.4%)
Close on Sep 18, 2026. Page updated Sep 19, 9:17 pm ET.
Gekko Brief
AI summaryAMETEK closes at $237.64, up 1.4%, sitting between its 50-day average of $241.36 and 200-day average of $227.85, a mixed trend picture. The GekkoIndex reads 60.9, placing the stock in the Accumulation zone. Price stands 6.6% above Gekko Fair Value of $223.02, a gap that bears watching.
This week's coverage centers on analyst target revisions and the closing of the Indicor deal. BNP Paribas Exane raised its price target to $290 from $280, maintaining an Outperform rating, citing the Indicor deal closing and strong financial performance, and projecting $10.60 in earnings per share by 2028. Shares have moved within a range tied to broader market swings, closing at $234.43 on 17 September after a 0.94% gain, and at $232.19 on 16 September, below the newly raised targets. A separate discounted cash flow analysis published 16 September put fair value near $158, contrasting with the analyst targets.
The next earnings date falls on 29 October, 39 days out and beyond a typical 20-trading-day hold; the prior report on 4 August showed EPS of $2.09 against a $1.99 estimate, an 8th straight beat, with a 4.5% reaction. Over the last 90 days, one insider purchase totaling $1,023,400 has been recorded. Consensus among 14 firms shows 10 buy and 4 hold ratings, with a $278.33 average target implying 17.1% upside. Seasonally, the next 20 trading days have averaged -1% over 5 years, rising in 2 of those years.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Price vs fair value
Close $237.64200-day averageGekko Fair Value $223.02
Key stats
- Market cap
- $54.47B
- P/E ratio
- 33.9
- Forward P/E
- 26.7
- EPS, TTM
- $6.91
- Revenue, TTM
- $7.86B
- Profit margin
- 20%
- Dividend yield
- 0.56%
- Beta
- 0.99
- Volume
- 1.44M avg 1.33M
- 1-year return
- +27.6%
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±3.9%
- 50-day average
- $241.36
- 200-day average
- $227.85
- Next earnings
- Oct 29 before open
- Shares outstanding
- 229.2M
AMETEK swing-trade checklist
AMETEK scores 3 supportive, 1 mixed and 2 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed2 headwinds
- Trendmixed
Averages disagree
Close $237.64 sits between the 50-day ($241.36) and 200-day ($227.85) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
60.9, Accumulation
Reading 60.9 is in the Accumulation zone.
See the GekkoIndex - Fair valueheadwind
6.6% above
Price is 6.6% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneysupportive
Leans bullish
Last 90 days: 1 open-market insider purchase.
See smart money - Earnings risksupportive
Reports in 39 days
Next report Oct 29, 2026, 39 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−1.0% on average
From this point in the calendar, the next 20 trading days averaged −1% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
AMETEK stock chart and price history
AMETEK closed at $237.64 on Sep 18, 2026, +27.6% over the past year, inside a 52-week range of $179.24 to $261.16.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −2.3%
- 3 months
- +0.1%
- 6 months
- +12.4%
- 1 year
- +27.6%
The full AME chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open AME in Gekko
Follow AMETEK through every session
Put AME on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track AME in GekkoFree for 7 days. No credit card required.
About AMETEK
AMETEK designs and builds electronic instruments and electromechanical equipment used across a wide range of industrial and technical settings. Its instruments handle tasks like process control, power monitoring, environmental sensing, and laboratory measurement, while its aviation-related products include aircraft sensors, fuel and fluid measurement tools, and data acquisition systems. The company is recognized for combining precision measurement technology with components built into aircraft, industrial machinery, and medical equipment.
The business runs through two main groups. One focuses on instrumentation for sectors such as oil and gas, pharmaceuticals, semiconductors, and food and beverage production, along with test and measurement equipment and power quality devices. The other produces engineered connectors, motion control products, specialty metals, motors, and thermal management systems for military and commercial aircraft as well as ground vehicles, and also runs aviation maintenance and repair facilities. Customers span aerospace, industrial, medical, and defense applications, among others.
AMETEK was founded in 1930 and is headquartered in Berwyn, Pennsylvania. Its shares are listed on the NYSE under the ticker AME.
- Listed
- NYSE
- Sector
- Producer manufacturing
- Industry
- Electrical products
- Website
- ametek.com
AMETEK GekkoIndex: the smart money zone
AMETEK’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.9, in the Accumulation zone, up 1 point over five sessions.
60.9Accumulation
Up 1 point over five sessions, from the Neutral zone.
Reading for Sep 18, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 19 | +2.1% | +4.7% | ||
| Accumulation (current zone) | 162 | +0.5% | +2.3% | ||
| Neutral | 439 | +0.1% | +1.0% | ||
| Distribution | 41 | +1.1% | 0.0% | ||
| Selling | 1 | Too few readings yet | |||
Average AME share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the AME price, zone by zone.Track AME in Gekko
Is AMETEK stock overvalued? Gekko Fair Value
AMETEK trades 6.6% above Gekko Fair Value of $223.02, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what AMETEK shares are worth, recalculated every trading day.
$223.02
Gekko Fair Value, Sep 19, 2026
6.6% Overvalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open AME in Gekko
AMETEK insider and Congress trading
Insiders filed 1 open-market purchase in AMETEK worth $1.02M, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in AME were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for AME, plotted on the chart in Gekko.Open AME in Gekko
Buybacks
AMETEK has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $265K
- As a share of market cap
- 0.00%
- Trailing four quarters
- $444.1M
From company filings.
Hedge funds and billionaires quarter ended Dec 31
0of the funds Gekko tracks hold AME.
0added0opened0trimmed2sold out
Which funds are on each side, name by name.Unlock in Gekko
AMETEK earnings: next date and track record
AMETEK reports on Oct 29, 2026, before the open (39 days away), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Oct 29, 2026
Expected before the open, 39 days away
- EPS estimate
- $2.11
- Revenue estimate
- $2.10B
8 of 8reports beat the EPS estimate
±3.3%average move across the report
6 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 4, 2026 AI summary
- What they said
- AMETEK reported a very strong Q2 2026 with record sales ($2.04B), record orders ($2.3B) and backlog ($4.11B), double-digit organic sales growth, margin expansion, exceptional free cash flow and record EPS ($2.09). Management highlighted broad-based strength across segments—semiconductor, MedTech, aerospace & defense, power, and automation—credited to a differentiated, IP-driven product portfolio, R&D investment, and disciplined operations. They raised full-year sales and earnings guidance and increased second-half expectations while noting conservatism in their outlook. Acquisition activity (FARO, Indicor pending) and AI initiatives were discussed as growth and productivity drivers. Overall tone was confident, with management emphasizing execution, margin expansion, productivity gains, and strong cash generation.
- Guidance
- Raised full-year sales and earnings guidance (no full-year numeric provided on the call). Segment 2026 organic sales expectations: Process up mid-single digits; Aerospace & Defense up low double digits; Power up mid-single digits; Automation & Engineered Solutions up high single digits. Full-year capital expenditures approx. $160 million (~2% of sales). Depreciation & amortization approx. $430 million for the year, including after-tax acquisition-related intangible amortization of approx. $210 million (~$0.91 per diluted share). 2026 expected effective tax rate 18.5%–19%. Management also said the revised H2 organic sales guide is 1.5–2 points stronger vs prior guide and Q2 EPS beat implies higher H2 sales/earnings; Q2 EPS was $2.09 (above prior guidance $1.96–$2.00).
- Risks flagged
- Standard forward-looking statement risks noted (SEC filings). Mentioned risks include variability in quarterly tax items, lumpy/order cadence variability, integration and regulatory approval risks for acquisitions (Indicor), potential acquisition-related diligence costs, and the general uncertainty that could cause actual results to differ from guidance. No new major macro downside items were emphasized on the call.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 4, 2026 | $2.09 est $1.99 | $2.04B est $1.95B | +4.5% |
| Apr 30, 2026 | $1.97 est $1.90 | $1.93B est $1.91B | +1.1% |
| Feb 3, 2026 | $2.01 est $1.94 | $2.00B est $1.95B | 0.0% |
| Oct 30, 2025 | $1.89 est $1.76 | $1.89B est $1.81B | +9.7% |
| Jul 31, 2025 | $1.78 est $1.69 | $1.78B est $1.73B | +3.2% |
| May 1, 2025 | $1.75 est $1.69 | $1.73B est $1.74B | +0.3% |
| Feb 4, 2025 | $1.87 est $1.85 | $1.76B est $1.82B | −2.1% |
| Oct 31, 2024 | $1.47 est $1.41 | $1.71B est $1.71B | +5.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
AMETEK stock forecast and analyst price targets
Analysts’ average 12-month price target for AMETEK is $278.33, +17.1% from the last close, from 14 firms rating the stock in the last 90 days.
$278.33consensus 12-month target, +17.1% from the last close
Now $237.64Avg $278.33
Low $245High $316
Each firm’s latest rating in the last 90 days: 14 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 8 | Vertical Research | $255 | +7.3% |
| Aug 28 | Oppenheimer | — | — |
| Aug 24 | Morgan Stanley | $245 | +3.1% |
| Aug 11 | Bank of America Securities | — | — |
| Aug 6 | TD Cowen | $275 | +15.7% |
+2.3%average 20-day move after past Accumulation readings
−1.0%average move over the next 20 trading days in the last 5 years
±2.1%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
AMETEK seasonality: the next 20 trading days
Over the next 20 trading days from Sep 19, AMETEK averaged −1.0% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.2% | 2 of 5 |
| Next 10 trading days | −2.4% | 0 of 5 |
| Next 15 trading days | −2.5% | 0 of 5 |
| Next 20 trading days | −1.0% | 2 of 5 |
| Next 30 trading days | +2.4% | 3 of 5 |
For scale, AME’s typical 20-trading-day move in either direction is about 3.9%.
AMETEK market cap and key statistics
AMETEK’s market cap is $54.47B, with a P/E ratio of 33.9 and revenue of $7.86B over the last twelve months.
Valuation
- Market cap
- $54.47B
- P/E ratio
- 33.9
- Forward P/E
- 26.7
- EPS, TTM
- $6.91
- Gekko Fair Value
- $223.02
Trading
- Volume
- 1.44M
- Avg volume, 20 days
- 1.33M
- 52-week high
- $261.16
- 52-week low
- $179.24
- Shares outstanding
- 229.2M
Financials
- Revenue, TTM
- $7.86B
- Profit margin
- 20%
- Return on equity
- 14.6%
- Quarterly earnings growth, YoY
- +14.2%
Risk and income
- Beta
- 0.99
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±3.9%
- Dividend yield
- 0.56%
AMETEK stock news this week
Coverage of AMETEK this week reads positive: 4 positive, 1 neutral and 0 negative headlines.
- AMETEK stock heads into the open after a 0.9% gainAD HOC NEWS, Sep 18
- AMETEK Inc. stock holds firm as analysts raise targets and investors eye next earningsAD HOC NEWS, Sep 17
- Is AME Overvalued? DCF Says Worth $158GuruFocus, Sep 16
- Ametek Inc. stock underperforms Monday when compared to competitorsMarketWatch, Sep 14
- Ametek Inc. stock outperforms competitors on strong trading dayMarketWatch, Sep 11
- BNP Paribas Exane raises Ametek stock price target to $290 on dealInvesting.com, Sep 11
AMETEK peers
AMETEK’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| GEVGE Vernova | Neutral | 4.9% above |
| ETNEaton | Neutral | 17.6% above |
| LITELumentum | Neutral | 3.5% below |
| ROKRockwell Automation | Accumulation | 8.9% above |
| HUBBHubbell | Accumulation | 13.1% below |
| GNRCGenerac | Neutral | 2.6% above |
A peer links to its own page where one exists.
AMETEK stock FAQ
What is AMETEK’s market cap?
AMETEK’s market cap is $54.47B at the Sep 18, 2026 close of $237.64, with 229.2M shares outstanding. The shares trade on a P/E ratio of 33.9.
What is the AMETEK stock forecast?
The consensus analyst 12-month price target for AMETEK is $278.33, +17.1% from the last close. Of the 14 firms that rated the stock in the last 90 days, 10 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is AMETEK stock overvalued or undervalued?
On Gekko’s estimate AMETEK is overvalued: the Sep 18, 2026 close of $237.64 is 6.6% above Gekko Fair Value of $223.02. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does AMETEK report earnings next?
AMETEK is expected to report on Oct 29, 2026, before the market opens (39 days away). Analysts expect earnings of $2.11 per share on revenue of $2.10B. AMETEK beat the earnings estimate in 8 of its last 8 reports, moving 3.3% on average across the report.
What is AMETEK’s 52-week high and low?
AMETEK’s 52-week high is $261.16 and its 52-week low is $179.24; it closed at $237.64 on Sep 18, 2026, +27.6% over the past year.
Is AMETEK stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (gekkoindex, smart money and earnings risk), 1 as mixed (trend) and 2 as headwinds (fair value and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See AMETEK the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.